AU6449200A - Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor - Google Patents
Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptorInfo
- Publication number
- AU6449200A AU6449200A AU64492/00A AU6449200A AU6449200A AU 6449200 A AU6449200 A AU 6449200A AU 64492/00 A AU64492/00 A AU 64492/00A AU 6449200 A AU6449200 A AU 6449200A AU 6449200 A AU6449200 A AU 6449200A
- Authority
- AU
- Australia
- Prior art keywords
- ghb
- hydroxybutyrate
- characterisation
- cloning
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 title 1
- 210000004556 brain Anatomy 0.000 title 1
- 238000012512 characterization method Methods 0.000 title 1
- 238000010367 cloning Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9907784A FR2795075A1 (en) | 1999-06-18 | 1999-06-18 | New rat brain gamma-hydroxybutyrate receptor and its encoding nucleic acid, useful for identifying agents for treating e.g. epilepsy |
FR9907784 | 1999-06-18 | ||
PCT/FR2000/001687 WO2000078948A2 (en) | 1999-06-18 | 2000-06-19 | Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6449200A true AU6449200A (en) | 2001-01-09 |
Family
ID=9547010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU64492/00A Abandoned AU6449200A (en) | 1999-06-18 | 2000-06-19 | Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU6449200A (en) |
FR (1) | FR2795075A1 (en) |
WO (1) | WO2000078948A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2406058A1 (en) * | 2000-04-10 | 2001-10-18 | Human Genome Sciences, Inc. | Tm4sf receptor polynucleotides, polypeptides, and antibodies |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003525566A (en) * | 1997-11-07 | 2003-09-02 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 125 human secreted proteins |
-
1999
- 1999-06-18 FR FR9907784A patent/FR2795075A1/en not_active Withdrawn
-
2000
- 2000-06-19 AU AU64492/00A patent/AU6449200A/en not_active Abandoned
- 2000-06-19 WO PCT/FR2000/001687 patent/WO2000078948A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
FR2795075A1 (en) | 2000-12-22 |
WO2000078948A3 (en) | 2001-03-01 |
WO2000078948A2 (en) | 2000-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6219398A (en) | Use of central cannabinoid receptor antagonists for regulating appetence | |
AU2711400A (en) | Heteroaryl-aryl ureas as igf-1 receptor antagonists | |
AU4499499A (en) | A polypeptide structure for use as a scaffold | |
AU3764300A (en) | Invertebrate biogenic amine receptors | |
AU4772096A (en) | Delta opioid receptor antagonists | |
PL337809A1 (en) | Derivatives of 1-aminoalkyl cyclohexane as antagonists of nmda receptor | |
EP1224173A4 (en) | Pyrazole derivatives as cannabinoid receptor antagonists | |
AUPP608898A0 (en) | New use of prostaglandin E2 antagonists | |
AU4394799A (en) | Retinoid-associated receptor regulators | |
AU2897497A (en) | Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors | |
CZ20011270A3 (en) | Tetrahydrobenzazepine derivatives suitable as modulators of dopamine D3 receptors | |
AU1553199A (en) | Antagonists of g-protein-coupled receptor | |
AU7667300A (en) | Use of central cannabinoid receptor antagonist for preparing medicines | |
AU9164998A (en) | Speech coding | |
AU6586298A (en) | Glucagon-like peptide-1 analogs | |
AU6343998A (en) | Constitutively activated serotonin receptors | |
AU4728799A (en) | Bivalent binding molecules of 7 transmembrane g protein-coupled receptors | |
EP1157038A4 (en) | Cloning of a p2y-like 7tm receptor (axor17) | |
AU6353098A (en) | NK-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome | |
AU2314195A (en) | Benzofuran derivatives as d4 receptor antagonists | |
AU6425098A (en) | Termination of a tension member, for use as a tendon for a tension leg platform | |
AU1535699A (en) | Novel receptors opg-2 | |
AU3339697A (en) | Indoline derivatives useful as 5-ht-2c receptor antagonists | |
AU6449200A (en) | Cloning, expression and characterisation of a cdna coding for a rat brain gamma-hydroxybutyrate (ghb) receptor | |
EP1073681A4 (en) | Cloning of a novel 7tm receptor axor-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |